drug,indication,company,pdufa_date,fda_date_no_pdufa,source_url
ORLADEYO (berotralstat),Hereditary angioedema (HAE),BioCryst Pharmaceuticals Inc,2025-09-12,,https://www.benzinga.com/fda-calendar/exact-dates
Atebimetinib + mGnP,in First-Line Pancreatic Cancer Patients,Immuneering Corporation,,2025-09-25,https://www.benzinga.com/fda-calendar/exact-dates
Aficamten,Symptomatic obstructive hypertrophic cardiomyopathy (oHCM),Cytokinetics Inc,2025-09-26,,https://www.benzinga.com/fda-calendar/exact-dates
Tolebrutinib,Brutonâ€™s tyrosine kinase (BTK) inhibitor,Sanofi SA,,2025-09-28,https://www.benzinga.com/fda-calendar/exact-dates
